Aldosterone nongenomically induces angiotensin II receptor dimerization in rat kidney: role of mineralocorticoid receptor and NADPH oxidase.
Autor: | Sinphitukkul K; Graduate Division, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Manotham K; Molecular and Cell Biology Unit, Department of Medicine, Lerdsin General Hospital, Bangkok, Thailand., Eiam-Ong S; Department of Medicine, Division of Nephrology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Eiam-Ong S; Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. |
---|---|
Jazyk: | angličtina |
Zdroj: | Archives of medical science : AMS [Arch Med Sci] 2019 Oct; Vol. 15 (6), pp. 1589-1598. Date of Electronic Publication: 2019 Aug 22. |
DOI: | 10.5114/aoms.2019.87135 |
Abstrakt: | Introduction: Previous in vitro studies demonstrated that aldosterone nongenomically induces transglutaminase (TG) and reactive oxygen species (ROS), which enhanced angiotensin II receptor (ATR) dimerization. There are no in vivo data in the kidney. Material and Methods: Male Wistar rats were intraperitoneally injected with normal saline solution, or aldosterone (Aldo: 150 μg/kg BW); or received pretreatment with eplerenone (mineralocorticoid receptor (MR) blocker, Ep. + Aldo), or with apocynin (nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, Apo. + Aldo) 30 min before aldosterone. Thirty minutes after aldosterone injection, protein abundances of dimeric and monomeric forms of AT Results: Protein abundances of dimeric forms of AT Conclusions: This is the first in vivo study demonstrating that aldosterone nongenomically increases renal TG2 and p47phox protein expression and then activates AT Competing Interests: The authors declare no conflict of interest. (Copyright: © 2019 Termedia & Banach.) |
Databáze: | MEDLINE |
Externí odkaz: |